Regulatory Landscape Shaping the North America Epoetin-alfa Market The global epoetin-alfa erythropoietin market is witnessing steady expansion driven by rising chronic disease prevalence and the growing demand for anemia management therapies worldwide. Epoetin-alfa, a recombinant erythropoietin, is widely used to stimulate red blood cell production in patients suffering from chronic kidney disease (CKD), cancer-related anemia, HIV treatment-related anemia, and post-surgical anemia. With increasing healthcare spending, expanding biologics adoption, and the emergence of biosimilars, the market is expected to experience stable growth through 2034. Read More - https://www.theinsightpartners.com/reports/epoetin-alfa-erythropoietin-market